Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights
- 28 July 2026
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 35 (8) , 1529-1542
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India (CSPS24/RDSF/IIIM/IHP24/03)
This publication has 44 references indexed in Scilit:
- Nootkatone as a multi-target modulator of the PD-L1/PD-1 signaling in pancreatic cancer: network pharmacology, docking, molecular dynamics, and DFT analysisNaunyn-Schmiedeberg's Archives of Pharmacology, 2026
- Management of Staphylococcus aureus BacteremiaJAMA, 2025
- Current status and recent trends in innovative tactics and the One Health approach to address the challenge of methicillin-resistant Staphylococcus aureus infections: a comprehensive reviewDiscover Medicine, 2025
- Breaking the resistance: integrative approaches with novel therapeutics against Klebsiella pneumoniaeArchives of Microbiology, 2024
- Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking studyPharmacological Reports, 2023
- Synthesis and biological evaluation of pentacyclic triterpenoid derivatives as potential novel antibacterial agentsBioorganic Chemistry, 2021
- Virtual Screening, Molecular Docking, and DFT Studies of Some Thiazolidine‐2,4‐diones as Potential PIM‐1 Kinase InhibitorsChemistrySelect, 2018
- Molecular modeling studies of some thiazolidine-2,4-dione derivatives as 15-PGDH inhibitorsMedicinal Chemistry Research, 2015
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Using AutoDock for Ligand‐Receptor DockingCurrent Protocols in Bioinformatics, 2008